Patient group direction (PGD)/national protocol for Novavax Nuvaxovid COVID-19 vaccine
Dear UK Health Security Agency (UKHSA),
I am writing to make a request for information under section 1 of the Freedom of Information Act 2000.
This request has three parts. I would appreciate if you could provide separate answers to each part.
1) Please can you confirm whether the UKHSA has developed either or both of the following for the administration of the Novavax Nuvaxovid COVID-19 vaccine in the UK:
a) A patient group direction (PGD)
b) A national protocol
2) Please can you confirm if the UKHSA has any draft versions of either or both of the above-listed documents, which are not the final versions for publication.
3) If the answer to (1) and/or (2) is in the affirmative, please can you provide me with these documents.
Yours faithfully,
Kenneth MacArthur
Dear Kenneth MacArthur,
Your request will be handled by the Information Rights Team at the UK
Health Security Agency (UKHSA). We acknowledge receipt of your email and
request for information, which will be treated as a request for
information under statutory access legislation. UKHSA has taken
responsibility for statutory access requests addressed to Public Health
England and NHS Test and Trace Services.
Please note that requests under the Freedom of Information Act and the
Environmental Information Regulations (EIRs) will receive a response
within 20 working days from the day following the date of receipt of your
request.
If the request is for your personal data, your request will be handled as
a data subject access request (SAR) under Article 15 of the General Data
Protection Regulation (GDPR), then we will respond within one month of the
receipt of the request.
The UK Health Security Agency is heavily involved in the government’s
response to the COVID-19 pandemic. We will aim to address all requests
promptly and within the required response timeframes. However, when we
are unable to meet the response timeframe we will keep requesters updated
on a revised expected timescale for a response to their request. The
Information Commissioner recognises this position in its recent guidance,
see link:
[1]https://ico.org.uk/media/2617613/ico-reg...
Yours sincerely,
Information Rights Team
UK Health Security Agency
[2][UKHSA request email]
[3]www.gov.uk/ukhsa Follow us on Twitter @UKHSA
══════════════════════════════════════════════════════════════════════════
From: Kenneth MacArthur <[FOI #860875 email]>
Sent: 10 May 2022 22:15
To: Information Rights <[email address]>
Subject: Freedom of Information request - Patient group direction
(PGD)/national protocol for Novavax Nuvaxovid COVID-19 vaccine
[You don't often get email from
[FOI #860875 email]. Learn why this is important at
[4]https://aka.ms/LearnAboutSenderIdentific...
EXTERNAL: This email originated outside of UKHSA. Do not click links or
attachments unless you recognise the sender.
Dear UK Health Security Agency (UKHSA),
I am writing to make a request for information under section 1 of the
Freedom of Information Act 2000.
This request has three parts. I would appreciate if you could provide
separate answers to each part.
1) Please can you confirm whether the UKHSA has developed either or both
of the following for the administration of the Novavax Nuvaxovid COVID-19
vaccine in the UK:
a) A patient group direction (PGD)
b) A national protocol
2) Please can you confirm if the UKHSA has any draft versions of either or
both of the above-listed documents, which are not the final versions for
publication.
3) If the answer to (1) and/or (2) is in the affirmative, please can you
provide me with these documents.
Yours faithfully,
Kenneth MacArthur
-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #860875 email]
Is [UKHSA request email] the wrong address for Freedom of
Information requests to UK Health Security Agency? If so, please contact
us using this form:
[5]https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[6]https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[7]https://eur01.safelinks.protection.outlo...
[8]https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed.
If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.
Dear Kenneth MacArthur,
Please find attached UKHSA's response to your request.
Yours sincerely,
Information Rights Team
UK Health Security Agency
[1][UKHSA request email]
[2]www.gov.uk/ukhsa Follow us on Twitter @UKHSA
══════════════════════════════════════════════════════════════════════════
From: Information Rights <[email address]>
Sent: 11 May 2022 10:18
To: Kenneth MacArthur <[FOI #860875 email]>
Cc: Information Rights <[email address]>
Subject: Re: FOI case ref 153
Dear Kenneth MacArthur,
Your request will be handled by the Information Rights Team at the UK
Health Security Agency (UKHSA). We acknowledge receipt of your email and
request for information, which will be treated as a request for
information under statutory access legislation. UKHSA has taken
responsibility for statutory access requests addressed to Public Health
England and NHS Test and Trace Services.
Please note that requests under the Freedom of Information Act and the
Environmental Information Regulations (EIRs) will receive a response
within 20 working days from the day following the date of receipt of your
request.
If the request is for your personal data, your request will be handled as
a data subject access request (SAR) under Article 15 of the General Data
Protection Regulation (GDPR), then we will respond within one month of the
receipt of the request.
The UK Health Security Agency is heavily involved in the government’s
response to the COVID-19 pandemic. We will aim to address all requests
promptly and within the required response timeframes. However, when we
are unable to meet the response timeframe we will keep requesters updated
on a revised expected timescale for a response to their request. The
Information Commissioner recognises this position in its recent guidance,
see link:
[3]https://ico.org.uk/media/2617613/ico-reg...
Yours sincerely,
Information Rights Team
UK Health Security Agency
[4][UKHSA request email]
[5]www.gov.uk/ukhsa Follow us on Twitter @UKHSA
══════════════════════════════════════════════════════════════════════════
From: Kenneth MacArthur <[FOI #860875 email]>
Sent: 10 May 2022 22:15
To: Information Rights <[email address]>
Subject: Freedom of Information request - Patient group direction
(PGD)/national protocol for Novavax Nuvaxovid COVID-19 vaccine
[You don't often get email from
[FOI #860875 email]. Learn why this is important at
[6]https://aka.ms/LearnAboutSenderIdentific...
EXTERNAL: This email originated outside of UKHSA. Do not click links or
attachments unless you recognise the sender.
Dear UK Health Security Agency (UKHSA),
I am writing to make a request for information under section 1 of the
Freedom of Information Act 2000.
This request has three parts. I would appreciate if you could provide
separate answers to each part.
1) Please can you confirm whether the UKHSA has developed either or both
of the following for the administration of the Novavax Nuvaxovid COVID-19
vaccine in the UK:
a) A patient group direction (PGD)
b) A national protocol
2) Please can you confirm if the UKHSA has any draft versions of either or
both of the above-listed documents, which are not the final versions for
publication.
3) If the answer to (1) and/or (2) is in the affirmative, please can you
provide me with these documents.
Yours faithfully,
Kenneth MacArthur
-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #860875 email]
Is [UKHSA request email] the wrong address for Freedom of
Information requests to UK Health Security Agency? If so, please contact
us using this form:
[7]https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[8]https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[9]https://eur01.safelinks.protection.outlo...
[10]https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed.
If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now